Literature DB >> 29390205

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

C Hiemke1,2, N Bergemann3, H W Clement4, A Conca5, J Deckert6, K Domschke7, G Eckermann8, K Egberts9, M Gerlach9, C Greiner10, G Gründer11, E Haen12, U Havemann-Reinecke13, G Hefner14, R Helmer15, G Janssen16, E Jaquenoud17, G Laux18, T Messer19, R Mössner20, M J Müller21, M Paulzen11, B Pfuhlmann22, P Riederer6, A Saria23, B Schoppek24, G Schoretsanitis25, M Schwarz26, M Silva Gracia12, B Stegmann12, W Steimer27, J C Stingl10, M Uhr28, S Ulrich29, S Unterecker6, R Waschgler30, G Zernig23,31, G Zurek32, P Baumann33.   

Abstract

Year:  2018        PMID： 29390205     DOI： 10.1055/s-0037-1600991

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN： 0176-3679            Impact factor:   5.788


× No keyword cloud information.
  36 in total

1.  Authors' Reply to Suhas et al.: Comment on: "Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation".

Authors:  Georgios Schoretsanitis; Maxim Kuzin; John M Kane; Christoph Hiemke; Michael Paulzen; Ekkehard Haen
Journal:  Clin Pharmacokinet       Date:  2021-04-26       Impact factor: 6.447

Review 2.  [Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].

Authors:  Stefan Unterecker; Gudrun Hefner; Pierre Baumann; Gerd Gründer; Niels Bergemann; Hans-Willi Clement; Andreas Conca; Jürgen Deckert; Katharina Domschke; Gabriel Eckermann; Karin Egberts; Manfred Gerlach; Christine Greiner; Ekkehard Haen; Ursula Havemann-Reinecke; Renate Helmer; Ger Janssen; Eveline Jaquenoud; Gerd Laux; Thomas Messer; Rainald Mössner; Matthias J Müller; Michael Paulzen; Bruno Pfuhlmann; Peter Riederer; Alois Saria; Bernd Schoppek; Georgios Schoretsanitis; Markus Schwarz; Margarethe Silva Gracia; Benedikt Stegmann; Werner Steimer; Julia C Stingl; Manfred Uhr; Sven Ulrich; Roland Waschgler; Gerald Zernig; Gabriele Zurek; Christoph Hiemke
Journal:  Nervenarzt       Date:  2019-05       Impact factor: 1.214

3.  The Impact of Smoking, Sex, Infection, and Comedication Administration on Oral Olanzapine: A Population Pharmacokinetic Model in Chinese Psychiatric Patients.

Authors:  Yan-Nan Zang; Fang Dong; An-Ning Li; Chuan-Yue Wang; Gui-Xin Guo; Qian Wang; Yan-Fang Zhang; Lei Zhang; Jose de Leon; Can-Jun Ruan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-03-06       Impact factor: 2.441

4.  CYP2C19-Guided Escitalopram and Sertraline Dosing in Pediatric Patients: A Pharmacokinetic Modeling Study.

Authors:  Jeffrey R Strawn; Ethan A Poweleit; Laura B Ramsey
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-02-28       Impact factor: 2.576

Review 5.  Possible Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions That Are Likely to Be Clinically Relevant and/or Frequent in Bipolar Disorder.

Authors:  Jose de Leon; Edoardo Spina
Journal:  Curr Psychiatry Rep       Date:  2018-03-12       Impact factor: 5.285

6.  What to Do About Missed Doses? A Retrospective Study of Olanzapine in the Elderly.

Authors:  Tao Xiao; Zhanzhang Wang; Guanlie Li; Shanqing Huang; Xiuqing Zhu; Shujing Liu; Xiaolin Li; Jinqing Hu; Dewei Shang; Yuguan Wen
Journal:  Drug Des Devel Ther       Date:  2021-08-04       Impact factor: 4.162

Review 7.  Optimized Dosing: The Next Step in Precision Medicine in Non-Small-Cell Lung Cancer.

Authors:  René J Boosman; Jacobus A Burgers; Egbert F Smit; Neeltje Steeghs; Anthonie J van der Wekken; Jos H Beijnen; Alwin D R Huitema; Rob Ter Heine
Journal:  Drugs       Date:  2021-12-11       Impact factor: 9.546

8.  Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers.

Authors:  Michel Arvidsson; Marja-Liisa Dahl; Olof Beck; Gerd Ackehed; Karin Nordin; Staffan Rosenborg
Journal:  Eur J Clin Pharmacol       Date:  2019-11-30       Impact factor: 2.953

9.  High-dose quetiapine and therapeutic monitoring.

Authors:  Hervé Javelot; Francis Rangoni; Luisa Weiner; Bruno Michel
Journal:  Eur J Hosp Pharm       Date:  2018-08-06

10.  The Effect of Body Weight Changes on Total Plasma Clozapine Concentrations Determined by Applying a Statistical Model to the Data From a Double-Blind Trial.

Authors:  Francisco J Diaz; Richard C Josiassen; Jose de Leon
Journal:  J Clin Psychopharmacol       Date:  2018-10       Impact factor: 3.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.